Detrusor Overactivity Completed Phase 4 Trials for Solifenacin (DB01591)

IndicationStatusPhase
DBCOND0035562 (Detrusor Overactivity)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01093534Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.Basic Science